- Report
- October 2023
- 186 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 188 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- October 2020
- 85 Pages
Global
€20996EUR$22,000USD£17,592GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Drug Pipelines
- January 2024
- 90 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 119 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2022
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- November 2023
- 163 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- December 2024
- 85 Pages
Spain
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2023
- 77 Pages
France
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 175 Pages
Global
From €4295EUR$4,500USD£3,598GBP

The Checkpoint Inhibitors market is a subset of the Oncology Drugs market, which focuses on treatments for cancer. Checkpoint Inhibitors are a type of immunotherapy, which works by blocking certain proteins that act as “checkpoints” in the body’s immune system. By blocking these checkpoints, the body’s immune system is able to recognize and attack cancer cells. This type of therapy has been found to be effective in treating a variety of cancers, including melanoma, non-small cell lung cancer, and bladder cancer.
The Checkpoint Inhibitors market is highly competitive, with many companies developing and marketing their own products. Some of the major players in the market include Merck, Bristol-Myers Squibb, Roche, AstraZeneca, and Pfizer. Show Less Read more